Constitutive expression of human cytomegalovirus (HCMV) glycoprotein gpUL75 (gH) in astrocytoma cells: A study of the specific humoral immune response

Viral Immunology

Volumn 12, Issue 3, 1999, Pages 249-262

  Reschke, Marko ^a,c   Revello, Maria Grazia ^b   Percivalle, Elena ^b   Radsak, Klaus ^c   Landini, Maria Paola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GENE PRODUCT; IMMUNOGLOBULIN G; MONOMER; VIRUS GLYCOPROTEIN;

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION;

DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0032884202     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1999.12.249     Document Type: Article

References (55)

1. Adler, S. 1995. Immunoprophylaxis against cytomegalovirus disease. Scand J. Inf. Dis. (Suppl) 99:105-109.
2. Anderson, R.A., D.X. Liu, and U.A. Gompels 1996. Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: Substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virol. 217:517-528.
3. Baboonian, C., K. Blake, J.C. Booth, and C.N. Wiblin. 1989. Complement-independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus. J. Med. Virol. 29:139-145.
4. Beninga, J., B. Kropff, and M. Mach. 1995. Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. J. Gen. Virol. 76:153-160.
5. Bogner, E., M. Reschke, B. Reis, E. Reis, W. Britt, and K. Radsak. 1992. Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Archives Virol. 126:67-80.
6. Bogner, E., B. Anheier, F. Öffner, C. Smuda, M. Reschke, M. Eickmann, and K. Radsak. 1997. Nuclear translocation of mutagenized forms of human cytomegalovirus glycoprotein B (gpUL55). J. Gen. Virol. 78:1647-1651.
7. Bold, S., M. Ohlin, W. Garten, and K. Radsak. 1996. Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion. J. Gen. Virol. 77:2297-2302.
8. Boppana, S.B., M.A. Polis, A.A. Kramer, W.J. Britt, and S. Koenig. 1995. Virus-specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis. J. Infect. Dis. 171:182-185.
9. Boppana, S.B., and W. Britt, 1996. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virol. 222:293-296.
10. Chee, M.S., A.T. Bankier, S. Beck, R. Bohni, C.M. Brown, R. Cerny, T. Horsnell, C.A. Hutchinson III, T. Kouzarides, J.A. Martignetti, E. Preddie, S.C. Satchwell, P. Tomlinson, K.M. Weston, and B.G. Barell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Topics Microbiol. Immunol. 154:125-169.
11. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
12. Cranage, M.P., G.L. Smith, S.E. Bell, H. Hart, C. Brown, A.T. Bankier, P. Tomlinson, B.G. Barell, & T.C. Minson. 1988. Identification and expression of a human cytomegalovirus glycoprotein with homology to the epsteinbarr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. Journal of Virology 62(4): 1416-1422.
13. Dal Monte, P., C. Bessia, A. Ripalti, M.P. Landini, A. Topilko, B. Plachter, J.L. Virelizier, and S. Michelson. 1996a. Stably expressed antisense RNA to cytomegalovirus UL86 inhibits viral replication. J. Virol. 70:4:2086-2094.
14. Dal Monte, P., C. Bessia, M.P. Landini, and S. Michelson. 1996b. Expression of human cytomegalovirus ppUL83 (pp65) in a stable cell line and its association with metaphase chromosomes. J. Gen. Virol. 77:2591-2596.
15. Duus, K.M., C. Hatfield, and C. Grose. 1995. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: Analysis by laser scanning confocal microscopy. Virol. 210:429-440.
16. Duus, K.M., and C. Grose. 1996. Multiple regularory effects of varizella-zoster virus (VZV) gL on trafficking patterns and fusugenic properties of VZV gH. J. Virol. 70:12:8961-8971.
17. Fleckenstein, B., I. Müller, and J. Collins. 1982. Cloning of the complete human cytomegalovirus genome in cosmids. Gene. 18:39-46.
18. Foà-Tomasi, L., E. Avitabile, A. Boscaro, R. Brandimarti, R. Guarlandri, R. Manservigi, F. Dall'Olio, R. Serafini-Cessi, and G. Campadelli-Fiume. 1991. Herpes simplex virus (HSV) glycoprotein H is partially processed in a cell line that expresses the glycoprotein and fully processed in cells infected with deletion or ts mutants in the known HSV glycoproteins. Virol. 180:474-482.
19. Gerna, G., G.M. Revello, E. Percivalle, M. Zavattoni, M. Parea, and M. Battaglia. 1990. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J. Clin. Microbiol. 28:12:2681-2688.
20. Gerna, G., M.G. Revello, M. Palla, E. Percivalle, and M. Torsellini. 1992a. Microneutralization as a reference method for selection of the cut-off of an enzyme-linked immunosorbent assay for detection of IgG antibody to human cytomegalovirus. Microbiologica. 15:177-182.
21. Gerna, G., M.G. Revello, E. Percivalle, and F. Morini. 1992b. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix protein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 30:5:1232-1237.
22. Gönczöl, E., K. Berencsi, E. Kaufmann, V. Endresz, S. Pincus, W. Cox, C. Meric, E. Paoletti, and S.A. Plotkin. 1995. Preclinical evaluation of an ALVAC (Canarypox)-human cytomegalovirus glycoprotein B vaccine candidate; Immune response elicited in a prime/boost protocol with the glycoprotein B subunit. Scand. J. Inf. Dis. (Suppl)99:110-112.
23. Gretch, D.R., B. Kari, L. Rasmussen, R.C. Gehrz, and M.F. Stinski. 1988. Identification and characterization of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus. J. Virol. 62:875-881.
24. Huber, M.T., and T. Compton. 1997. Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol. 71:7:5391-5398.
25. Huber, M.T., and T. Compton. 1998. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H - glycoprotein L - containing envelope complex. J. Virol. 72:10:8191-8197.
26. Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A.C. Minson, and D.C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:4:2240-2250.
27. Kari, B., R. Radeke, and R. Gehrz. 1992. Processing of human cytomegalovirus envelope glycoproteins in and egress of cytomegalovirus from human astrocytoma cells. J. Gen. Virol. 73:253-260.
28. Kaye, J.F., U.A. Gompels, and A.C. Minson. 1992. Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol. 73:2693-2698.
29. Klein, M., K. Schoppel, N. Amvrossiadis, and M. Mach. 1999. Strain-specific neutralization of human cytomegalovirus isolates by human sera. J. Virol. 73:2:878-886.
30. Kniess, N., M. Mach, J. Fay, and W.J. Britt. 1991. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. J. Virol. 65:138-146.
31. Landini, M.P., and M. Mach. 1995. Searching for antibodies specific for human cytomegalovirus: Is it diagnostically useful? When and how. Scand. J. Infect. Dis. (Suppl)99:18-23.
32. Lazzarotto, T., G.T. Maine, P. Dal Monte, A. Ripalti, and M.P. Landini. 1997. A novel western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M deteccion. J. Clin. Microbiol. 35:2:393-397.
33. Li, L., K.I. Coelingh, and W.J. Britt. 1995. Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J. Virol. 69:10:6047-6053.
34. Li, L., J.A. Nelson, and WJ. Britt. 1997. Glycoprotein H-related complexes of human cytomegalovirus: Identification of a third protein of the gcIII complex. J. Virol. 71:4:3090-3097.
35. Liu, D.X., U.A. Gompels, J. Nicholas, and C. Lelliot. 1993. Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein. J. Gen. Virol. 74:1847-1857.
36. Pachl, C., W.S. Probert, K.M. Hermsen, F.K. Masiarz, L. Rasmussen, T.C. Merigan, and R.R. Spaete. 1989. The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein gp86. Virol. 169:418-426.
37. Radsak, K., K. Brücher, W.J. Britt, D. Schneider, H. Shiou, and A. Kollert. 1990. Nuclear compartmentation of glycoprotein B of human cytomegalovirus. Virol. 177:515-522.
38. Rasmussen, L., C. Matkin, R. Spaete, C. Pachl, and T.C. Merigan. 1991. Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J. Infect. Dis. 164:835-842.
39. Rasmussen, L., S. Morris, R. Wolitz, A. Dowling, J. Fessell, M. Holodniy, and T.C. Merigan. 1994. Deficiency in antibody response to human cytomegalovirus glycoprotein gH in human immunodeficiency virus-infected patients at risk for cytomegalovirus retinitis. J. Infect. Dis. 170:673-677.
40. Reis, B., E. Bogner, M. Reschke, A. Richter, T.H. Mockenhaupt, and K. Radsak. 1993. Stable constitutive expression of glycoprotein B (gpUL55) of human cytomegalovirus in permissive astrocytoma cells. J. Gen. Virol. 74:1371-1379.
41. Reschke, M., B. Reis, K. Nöding, D. Rohsiepe, A. Richter, T. Mockenhaupt, W. Garten, and K. Radsak. 1995. Constitutive expression of human cytomegalovirus glycoprotein B (gpUL55) with mutagenized carboxy-terminal hydrophobic domains. J. Gen. Virol. 76:113-122.
42. Reschke, M., E. Bogner, S. Bold, M. Eickmann, T. Mockenhaupt, and K. Radsak. 1995b. Constitutive eukaryotic expression of authentic and mutagenized glycoprotein H of human cytomegalovirus in permissive astrocytoma cells. 5th International Cytomegalovirus Conference, May 21-24, Stockholm, Sweden, Abstract P063.
43. Reschke, M., G. Revello, E. Percivalle, K. Radsak, and M.P. Landini. 1997. Human cytomegalovirus glycoprotein H (gpUL75) constitutively expressed in permissive astrocytoma cells is very efficiently recognised by human antibodies. 6th International Cytomegalovirus Conference, March 5-9, Perdido Beach, Alabama, USA, Abstract.
44. Ripalti, A., M.C. Boccuni, F. Campanini, and M.P. Landini. 1995. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: Identification of an essential gene. J. Virol. 69:4:2047-2057.
45. Robbins, J.B., R. Scheerson, and S.C. Szu. 1995. Perspective: Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
46. Roop, C., L. Hutchinson, and D.C. Johnson. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:4:2285-2297.
47. Schoppel, K., B. Kropff, C. Schmidt, R. Vornhagen, and M. Mach. 1997. The humoral response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J. Infect. Dis. 175:533-544.
48. Simpson, J.A., J.C. Chow, J. Baker, N. Avdalovic, S. Yuan, D. Au, M. Co, M. Vasquez, W.J. Britt, and K.L. Coelingh. 1993. Neutralizing monoclonal antibodies that distinguish three antigenic sites of human cytomegalovirus glycoprotein H have conformationally distinct binding sites. J. Virol. 67:1:489-496.
49. Spaete, R., A. Saxena, P. Scott, G. Song, W. Probert, W.J. Britt, W. Gibson, L. Rasmussen, and C. Pachl. 1990. Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. J. Virol. 64:2922-2931.
50. Spaete, R.R., K. Perot, P.I. Scott, J.A. Nelson, M.F. Stinsky, and C. Pachl. 1993. Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virol. 193:853-861.
51. Spaete, R.R., R.C. Gehrz, and M.L. Landini. 1994. Human cytomegalovirus structural proteins. J. Gen. Virol. 75:3287-3308.
52. Urban, M., W. Britt, and M. Mach. 1992. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific. J. Virol. 66:3:1303-1311.
53. Urban, M., T. Winkler, M.P. Landini, W. Britt, and M. Mach. 1994. Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus. J. Infect. Dis. 169:83-90.
54. Urban, M., M. Klein, W.J. Britt, E. Hassfurther, and M. Mach. 1996. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. J. Gen. Virol. 77:7:1537-1547.
55. Wagner, B., B. Kropff, H. Kalbacher, W.J. Britt, V.A. Sundqvist, L. Ostberg, and M. Mach. 1992. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. J. Virol 66:5290-5297.